Protara Therapeutics, Inc. Investing Cash Flow
Protara Therapeutics, Inc. (TARA) reported Investing Cash Flow of $3.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $17.75M.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$14.72M.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$26.91M, a 219.59% decline year-over-year.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$6.51M.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$139.49M, a 828.22% decline from fiscal 2024.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $19.16M, a 63.93% decline from fiscal 2023.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $53.11M, a 255.23% increase from fiscal 2022.
- Protara Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $14.95M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.03M 10-Q · filed 2026-08-11 | -$23.88M derived: sum of 3 quarters · filed 2026-08-11 | -$30.38M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$14.72M 10-Q · filed 2026-05-13 | -$41.63M derived: sum of 2 quarters · filed 2026-05-13 | -$48.13M derived: sum of 3 quarters · filed 2026-05-13 | -$95.86M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$26.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$33.41M derived: sum of 2 quarters · filed 2026-03-10 | -$81.14M derived: sum of 3 quarters · filed 2026-08-11 | -$139.49M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$6.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$54.23M derived: sum of 2 quarters · filed 2026-08-11 | -$112.58M 10-Q · filed 2025-11-10 | -$90.08M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$47.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$106.08M 10-Q · filed 2026-08-11 | -$83.58M derived: sum of 3 quarters · filed 2026-08-11 | -$112.97M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$58.35M 10-Q · filed 2026-05-13 | -$35.85M derived: sum of 2 quarters · filed 2026-05-13 | -$65.24M derived: sum of 3 quarters · filed 2026-05-13 | -$62.30M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$6.89M derived: sum of 2 quarters · filed 2026-03-10 | -$3.94M derived: sum of 3 quarters · filed 2026-03-10 | $19.16M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | -$29.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$26.45M derived: sum of 2 quarters · filed 2025-11-10 | -$3.35M 10-Q · filed 2025-11-10 | $11.17M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $26.05M 10-Q · filed 2025-08-11 | $40.56M derived: sum of 3 quarters · filed 2025-08-11 | $46.94M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $23.10M 10-Q · filed 2025-05-08 | $37.62M derived: sum of 2 quarters · filed 2025-05-08 | $44.00M derived: sum of 3 quarters · filed 2025-05-08 | $66.35M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $14.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $20.90M derived: sum of 2 quarters · filed 2025-03-05 | $43.25M derived: sum of 3 quarters · filed 2025-03-05 | $53.11M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $28.73M derived: sum of 2 quarters · filed 2024-11-12 | $38.59M 10-Q · filed 2024-11-12 | $20.24M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $22.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $32.21M 10-Q · filed 2024-08-06 | $13.87M derived: sum of 3 quarters · filed 2024-08-06 | $32.91M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $9.86M 10-Q · filed 2024-05-02 | -$8.48M derived: sum of 2 quarters · filed 2024-05-02 | $10.56M derived: sum of 3 quarters · filed 2024-05-02 | $24.07M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | -$18.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $703.00K derived: sum of 2 quarters · filed 2024-03-13 | $14.21M derived: sum of 3 quarters · filed 2024-03-13 | $14.95M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $19.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $32.55M derived: sum of 2 quarters · filed 2023-11-03 | $33.30M 10-Q · filed 2023-11-03 | $35.18M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $14.25M 10-Q · filed 2023-08-03 | $16.14M derived: sum of 3 quarters · filed 2023-08-03 | $16.24M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $745.00K 10-Q · filed 2023-05-04 | $2.63M derived: sum of 2 quarters · filed 2023-05-04 | $2.74M derived: sum of 3 quarters · filed 2023-05-04 | $800.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.00M derived: sum of 2 quarters · filed 2023-03-08 | $55.00K derived: sum of 3 quarters · filed 2023-03-08 | -$98.19M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.83M derived: sum of 2 quarters · filed 2022-11-03 | -$100.08M 10-Q · filed 2022-11-03 | -$100.59M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$100.19M 10-Q · filed 2022-08-09 | -$100.70M derived: sum of 3 quarters · filed 2022-08-09 | -$100.83M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$98.25M 10-Q · filed 2022-05-05 | -$98.76M derived: sum of 2 quarters · filed 2022-05-05 | -$98.89M derived: sum of 3 quarters · filed 2022-05-05 | -$98.89M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$643.00K derived: sum of 2 quarters · filed 2022-03-09 | -$637.00K derived: sum of 3 quarters · filed 2022-03-09 | $2.83M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$126.00K derived: sum of 2 quarters · filed 2021-11-04 | $3.35M 10-Q · filed 2021-11-04 | $3.35M 10-Q · filed 2020-11-12 | $3.30M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.48M 10-Q · filed 2021-08-05 | $3.48M 10-Q · filed 2020-07-31 | $3.43M derived: sum of 3 quarters · filed 2021-08-05 | $3.11M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $3.47M 10-Q · filed 2021-05-06 | $3.47M 10-Q · filed 2020-05-13 | $3.43M derived: sum of 2 quarters · filed 2021-05-06 | $3.10M derived: sum of 3 quarters · filed 2021-05-06 | $3.02M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$45.86K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$371.26K derived: sum of 2 quarters · filed 2021-03-11 | -$447.89K derived: sum of 3 quarters · filed 2021-03-11 | -$475.00K 10-K · filed 2021-03-11 | $2.48M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | -$325.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$402.02K derived: sum of 2 quarters · filed 2020-11-12 | -$429.14K 10-Q · filed 2020-11-12 | $2.48M 10-Q · filed 2019-10-31 | $4.98M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | -$76.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$103.74K 10-Q · filed 2020-07-31 | $2.48M 10-Q · filed 2019-08-07 | $5.31M derived: sum of 3 quarters · filed 2020-07-31 | $11.31M derived: sum of 4 quarters · filed 2020-07-31 | |||
| 2019-03-31 | -$27.11K 10-Q · filed 2020-05-13 | $2.48M 10-Q · filed 2019-05-08 | $5.39M derived: sum of 2 quarters · filed 2020-05-13 | $11.39M derived: sum of 3 quarters · filed 2020-05-13 | $8.89M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $11.42M derived: sum of 2 quarters · filed 2020-03-20 | $8.92M derived: sum of 3 quarters · filed 2020-03-20 | $18.43M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $3.51M derived: sum of 2 quarters · filed 2019-10-31 | $13.01M 10-Q · filed 2019-10-31 | $19.46M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | -$2.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $7.01M 10-Q · filed 2019-08-07 | $13.46M derived: sum of 3 quarters · filed 2019-08-07 | -$634.00K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $9.51M 10-Q · filed 2019-05-08 | $15.95M derived: sum of 2 quarters · filed 2019-05-08 | $1.86M derived: sum of 3 quarters · filed 2019-05-08 | -$11.51M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$7.64M derived: sum of 2 quarters · filed 2019-03-13 | -$21.01M derived: sum of 3 quarters · filed 2019-03-13 | -$16.10M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$14.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$27.46M derived: sum of 2 quarters · filed 2018-11-07 | -$22.55M 10-Q · filed 2018-11-07 | -$7.22M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$13.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$8.45M 10-Q · filed 2018-08-07 | $6.87M derived: sum of 3 quarters · filed 2019-03-13 | |||||
| 2017-03-31 | $4.91M 10-Q · filed 2018-05-09 | $20.24M derived: sum of 2 quarters · filed 2019-03-13 | ||||||
| 2016-12-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $19.92M 10-K · filed 2019-03-13 | ||||||
| 2016-09-30 | $4.59M 10-Q · filed 2017-11-07 | |||||||
| 2015-12-31 | -$11.33M 10-K · filed 2018-03-14 | |||||||
| 2014-09-30 | -$16.16M 10-Q · filed 2014-11-25 | |||||||
| 2013-09-30 | $5.05M 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |